BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: El‐serag HB. Epidemiology of Hepatocellular Carcinoma. In: Arias IM, Alter HJ, Boyer JL, Cohen DE, Shafritz DA, Thorgeirsson SS, Wolkoff AW, editors. The Liver. Wiley; 2020. pp. 758-72. [DOI: 10.1002/9781119436812.ch59] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou C, Xia Y, Wei Y, Cheng L, Wei J, Guo B, Meng F, Cao S, van Hest JCM, Zhong Z. GE11 peptide-installed chimaeric polymersomes tailor-made for high-efficiency EGFR-targeted protein therapy of orthotopic hepatocellular carcinoma. Acta Biomater 2020;113:512-21. [PMID: 32562803 DOI: 10.1016/j.actbio.2020.06.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
2 Arslan F, Franci G, Maria Nastri B, Pagliano P. Hepatitis B virus-induced hepatocarcinogenesis: A virological and oncological perspective. J Viral Hepat 2021;28:1104-9. [PMID: 34003561 DOI: 10.1111/jvh.13551] [Reference Citation Analysis]
3 Chahal D, Marquez V, Hussaini T, Kim P, Chung SW, Segedi M, Chartier-Plante S, Scudamore CH, Erb SR, Salh B, Yoshida EM. End stage liver disease etiology & transplantation referral outcomes of major ethnic groups in British Columbia, Canada: A cohort study. Medicine (Baltimore) 2021;100:e27436. [PMID: 34678872 DOI: 10.1097/MD.0000000000027436] [Reference Citation Analysis]
4 Hemlata, Gupta S, Tejavath KK. ROS-Mediated Apoptosis Induced by BSA Nanospheres Encapsulated with Fruit Extract of Cucumis prophetarum in Various Human Cancer Cell Lines. ACS Omega 2021;6:10383-95. [PMID: 34056191 DOI: 10.1021/acsomega.1c00755] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Huang YJ, Acquati C, Cheung M. Family communication and coping among racial-ethnic minority cancer patients: A systematic review. Health Soc Care Community 2021. [PMID: 34716631 DOI: 10.1111/hsc.13623] [Reference Citation Analysis]
6 Lee H, Choi JY, Joung J, Joh J, Kim JM, Hyun SH. Metabolism-Associated Gene Signatures for FDG Avidity on PET/CT and Prognostic Validation in Hepatocellular Carcinoma. Front Oncol 2022;12:845900. [DOI: 10.3389/fonc.2022.845900] [Reference Citation Analysis]
7 Lin JH, Lin YH, Chao HC, Chang DM, Hong DW. A clinical empirical study on the role of refined rice bran in the prevention and improvement of metabolic syndrome. J Food Biochem 2020;44:e13492. [PMID: 33000482 DOI: 10.1111/jfbc.13492] [Reference Citation Analysis]
8 Fawzi Kabil M, Nasr M, El-Sherbiny IM. Conventional and hybrid nanoparticulate systems for the treatment of hepatocellular carcinoma: An updated review. Eur J Pharm Biopharm 2021;167:9-37. [PMID: 34271117 DOI: 10.1016/j.ejpb.2021.07.003] [Reference Citation Analysis]
9 Ameri M, Salimi H, Eskandari S, Nezafat N. Identification of potential biomarkers in hepatocellular carcinoma: A network-based approach. Informatics in Medicine Unlocked 2022. [DOI: 10.1016/j.imu.2022.100864] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Nofal AE, Shatla IM, Abdelhafeez DA, Mustafa M, Aly OM. OMA1520 and OMA1774, novel 1,2,4-triazole bearing analogs of combretastatin A-4, inhibit hepatocellular carcinoma: Histological and immunohistochemical studies. Biomed Pharmacother 2021;138:111417. [PMID: 33752057 DOI: 10.1016/j.biopha.2021.111417] [Reference Citation Analysis]